October 11, 2024

Life Sciences Snapshot – Q3 2024 – A Quarterly Report on Financing Trends

Carsten Bernauer, Tony Chan, Edward Dyson, Craig Falls, David Gindler, Gregg Griner, Blake Ilstrup, Scott Iyama, Thora Johnson, Neel Lilani, Ed Lukins, Mike O'Donnell, David Schulman, Gargi Talukder, Stephen Thau, Albert Vanderlaan, Alex Wood

Orrick, Herrington & Sutcliffe LLP

+ Follow Contact

Facebook

Send

Embed

This report series examines quarterly trends in life sciences venture investment. Key findings for Q2 2024 include: • Life sciences VC deal value reached $10.6 billion in Q2 2024, up more than 30% from Q1, which brings the YTD total to $18.6 billion. In a positive sign for the industry, YTD deal value exceeds that of the same period last year by 40.2%, and it appears that 2024 dealmaking is on track for annual growth after two consecutive years of declines.

Please see full publication below for more information.

View PDF

Download PDF [910KB]

Report

LOADING PDF: If there are any problems, click here to download the file.

Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.